A

argenx

Develops antibody-based therapies for autoimmune diseases

DT Artificial Intelligence Platform Lead

Applied Machine LearningConfirmed live in the last 24 hours
Full-timeGhent, Belgium

About the Job

Requirements

  • Knowledge of modern AI and machine learning platform architectures, MLOps frameworks, and tools for model development, training, deployment, and monitoring.
  • Knowledge and understanding of Agentic AI frameworks and management of the lifecycle of AI agents.
  • Skill in shaping enterprise technology strategy and developing multi-year roadmaps for AI and machine learning platform portfolios.
  • Knowledge of financial management and procurement, including experience managing large budgets, complex vendor contracts, and technology lifecycle planning.
  • Skill in leading senior technical and MLOps engineering teams and influencing data science leaders to align on technical direction and best practices.
  • Ability to work collaboratively within cross-functional teams and networks.
  • Communication skills in a multicultural and multilingual global environment.
  • Adaptability, comfort with ambiguity, trust-building, and resilience.
  • Experience operating in a dynamic, complex, fast-moving, and frequently changing business environment.
  • Demonstrable experience with project management, proactive planning, priority setting, and securing alignment.
  • Ability to drive toward outcomes.
  • Bachelor's or Master's degree preferred in Computer Science, Engineering, Artificial Intelligence, Data Science, or a related field relevant to the function.
  • 12+ years of experience in a senior leadership role accountable for enterprise-scale AI platforms, MLOps, or data science infrastructure in a global, regulated industry.
  • 8+ years of experience shaping long-term AI technology strategy, managing significant budgets, and leading teams of senior engineers or MLOps specialists.
  • 3+ years of experience deploying generative AI technology, introducing large language models, and enterprise AI tools.

Responsibilities

  • Provide overall leadership for the enterprise AI platform and MLOps frameworks, including LLMOps, managing associated personnel, vendors, and budget to ensure robust operationalization of AI models.
  • Lead the strategic direction and roadmap for the AI platform to provide an efficient and scalable environment for the end-to-end model lifecycle.
  • Drive adoption of standardized MLOps practices and frameworks to accelerate model development, improve reliability, ensure reproducibility, and enable governance.
  • Partner with data science teams and business units to ensure the AI platform meets evolving needs, removes friction, and enables tangible business value.
  • Own full lifecycle management for the AI platform portfolio, including Agentic AI, and make strategic investment decisions about new technologies, tools, upgrades, and retirements.
  • Own full lifecycle management for enterprise AI tools and make strategic investment decisions about new technologies, tools, upgrades, and retirements.
  • Ensure the AI platform adheres to security, compliance, and ethical AI standards in partnership with governance and security teams.
  • Champion engineering excellence and innovation within the platform team.

Desired Qualifications

  • Ability and eagerness to continuously learn, self-improve, and develop, including comfort giving and receiving feedback in a diverse environment.
  • Preparedness to contribute to a culture driven by co-creation, innovation, empowerment, excellence, and humility.

About the Company

argenx

Develops antibody-based therapies for autoimmune diseases

Argenx develops and markets antibody-based therapies for severe autoimmune diseases, turning immunology research into medicines. Its lead drug, efgartigimod (VYVGART), and the subcutaneous VYVGART Hytrulo treat conditions like generalized myasthenia gravis and CIDP by modulating the immune system through FcRn pathways. The company differentiates itself with antibody engineering and a co-creation model with academic and industry partners, plus a pipeline targeting FcRn-, complement-, and other autoimmune pathways and a global development footprint. Its goal is to provide effective antibody medicines for autoimmune diseases and broaden global patient access.

Company size
1,001-5,000
Company stage
IPO
Headquarters
Amsterdam, Netherlands
Founded
2008

Recently Posted Jobs

Explore more opportunities at argenx

See more jobs